Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04581343
Title A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic PC Patients (PanCAN-SR1)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pancreatic Cancer Action Network
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
New York University New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field